PAVmed Inc
NASDAQ:PAVM
PAVmed Inc
Interest Income Expense
PAVmed Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
PAVmed Inc
NASDAQ:PAVM
|
Interest Income Expense
-$7.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$375m
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-15%
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$554m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-6%
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
$97m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$296m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$227m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
29%
|
See Also
What is PAVmed Inc's Interest Income Expense?
Interest Income Expense
-7.5m
USD
Based on the financial report for Mar 31, 2024, PAVmed Inc's Interest Income Expense amounts to -7.5m USD.
What is PAVmed Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-7%
Over the last year, the Interest Income Expense growth was -358%.